Marina Josselin

PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor

Kelly Airiau, F-X Mahon, Marina Josselin et al. · Cell Death and Disease · 2013 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

ABT-737 increases tyrosine kinase inhibitor–induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38− population to imatinib

Kelly Airiau, François‐Xavier Mahon, Marina Josselin et al. · Experimental Hematology · 2012 · 32 citations

Medicine, Hematology, Oncology +15

A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib

Vanessa Augis, Kelly Airiau, Marina Josselin et al. · PLoS ONE · 2013 · 32 citations · Full text

Medicine, Genetics, Hematology +15